Vara receives CE mark for first autonomous breast cancer screening

Vara receives CE mark for first autonomous breast cancer screening is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-09-04

The AI-enabled device can report screenings it determines are normal without radiologist review.

Source: MedTech Dive